Latest Rosalind Advisors, Inc. Stock Portfolio
$248Million– No. of Holdings #32
Rosalind Advisors, Inc. Performance:
2026 Q1: -10.95%YTD: -10.95%2025: 14.98%
Performance for 2026 Q1 is -10.95%, and YTD is -10.95%, and 2025 is 14.98%.
About Rosalind Advisors, Inc. and 13F Hedge Fund Stock Holdings
On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Rosalind Advisors, Inc. reported an equity portfolio of $248.9 Millions as of 31 Mar, 2026.
The top stock holdings of Rosalind Advisors, Inc. are DCTH, XERS, FENC. The fund has invested 12.3% of it's portfolio in DELCATH SYSTEMS, INC. and 7.5% of portfolio in XERIS BIOPHARMA HOLDINGS INC.
The fund managers got completely rid off REPLIMUNE GROUP INC (REPL), ASTRIA THERAPEUTICS INC (LIFE) and CYTOKINETICS INC (CYTK) stocks. They significantly reduced their stock positions in CG ONCOLOGY INC, VIRIDIAN THERAPEUTICS INC (VRDN) and PROFOUND MEDICAL CORP (PROF). Rosalind Advisors, Inc. opened new stock positions in VAXCYTE INC (PCVX), VOR BIOPHARMA INC (VOR) and CELLDEX THERAPEUTICS INC (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to XERIS BIOPHARMA HOLDINGS INC (XERS), EYEPOINT PHARMACEUTICALS INC (EYPT) and X4 PHARMACEUTICALS INC (XFOR).
The top stock holdings of Rosalind Advisors, Inc. are DCTH, XERS, FENC. The fund has invested 12.3% of it's portfolio in DELCATH SYSTEMS, INC. and 7.5% of portfolio in XERIS BIOPHARMA HOLDINGS INC.
The fund managers got completely rid off REPLIMUNE GROUP INC (REPL), ASTRIA THERAPEUTICS INC (LIFE) and CYTOKINETICS INC (CYTK) stocks. They significantly reduced their stock positions in CG ONCOLOGY INC, VIRIDIAN THERAPEUTICS INC (VRDN) and PROFOUND MEDICAL CORP (PROF). Rosalind Advisors, Inc. opened new stock positions in VAXCYTE INC (PCVX), VOR BIOPHARMA INC (VOR) and CELLDEX THERAPEUTICS INC (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to XERIS BIOPHARMA HOLDINGS INC (XERS), EYEPOINT PHARMACEUTICALS INC (EYPT) and X4 PHARMACEUTICALS INC (XFOR).
Rosalind Advisors, Inc. Equity Portfolio Value
Last Reported on: 14 May, 2026
Rosalind Advisors, Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Rosalind Advisors, Inc. made a return of -10.95% in the last quarter. In trailing 12 months, it's portfolio return was 19.79%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| vaxcyte inc | 16,851,900 |
| vor biopharma inc | 12,488,000 |
| celldex therapeutics inc | 10,467,600 |
| biocryst pharmaceuticals inc | 8,787,500 |
| atea pharmaceuticals inc | 6,304,580 |
| ovid therapeutics inc | 2,459,750 |
| definium therapeutics inc | 2,362,500 |
| lipocine inc | 1,770,710 |
New stocks bought by Rosalind Advisors, Inc.
Additions
| Ticker | % Inc. |
|---|---|
| xeris biopharma holdings inc | 53.04 |
| eyepoint pharmaceuticals inc | 50.25 |
| x4 pharmaceuticals inc | 23.36 |
| verastem inc | 19.57 |
| fennec pharmaceuticals inc | 11.28 |
| biofrontera inc | 2.03 |
| myomo inc | 0.2 |
Additions to existing portfolio by Rosalind Advisors, Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| cg oncology inc | -66.67 |
| viridian therapeutics inc | -44.36 |
| onkure therapeutics inc | -39.25 |
| profound medical corp | -22.53 |
| polypid ltd | -14.16 |
| cybin inc | -7.59 |
| talphera inc | -6.3 |
| savara inc | -5.88 |
Rosalind Advisors, Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| replimune group inc | -13,710,000 |
| astria therapeutics inc | -13,601,600 |
| mind medicine mindmed inc | -10,042,500 |
| ocular therapeutix, inc | -4,856,000 |
| fractyl health inc | -848,608 |
| arrivent biopharma inc | -4,343,320 |
| cytokinetics inc | -12,393,200 |
| trevi therapeutics inc | -1,252,000 |
Rosalind Advisors, Inc. got rid off the above stocks
Sector Distribution
Rosalind Advisors, Inc. has about 83.3% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 83.3 |
| Others | 16.7 |
Market Cap. Distribution
Rosalind Advisors, Inc. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- MICRO-CAP
- UNALLOCATED
- MID-CAP
- NANO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 49.2 |
| MICRO-CAP | 22 |
| UNALLOCATED | 16.7 |
| MID-CAP | 8.9 |
| NANO-CAP | 3.2 |
Stocks belong to which Index?
About 59.4% of the stocks held by Rosalind Advisors, Inc. either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 59.4 |
| Others | 40.6 |
Rosalind Advisors, Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Rosalind Advisors, Inc.
Rosalind Advisors, Inc. has 32 stocks in it's portfolio. About 65.9% of the portfolio is in top 10 stocks. XERS proved to be the most loss making stock for the portfolio. was the most profitable stock for Rosalind Advisors, Inc. last quarter.
Last Reported on: 14 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRX | talphera inc | 1.01 | 3,353,920 | 2,505,040 | reduced | -6.3 | ||
| ANNX | annexon inc | 0.44 | 200,000 | 1,108,000 | new | |||
| AQST | aquestive therapeutics inc | 0.42 | 250,000 | 1,037,500 | new | |||
| AVIR | atea pharmaceuticals inc | 2.53 | 1,171,860 | 6,304,580 | new | |||
| AVTX | avalo therapeutics inc | 0.45 | 75,000 | 1,119,750 | new | |||
| BCRX | biocryst pharmaceuticals inc | 3.53 | 923,057 | 8,787,500 | new | |||
| BFRI | biofrontera inc | 0.38 | 1,163,960 | 941,645 | added | 2.03 | ||
| CLDX | celldex therapeutics inc | 4.21 | 330,000 | 10,467,600 | new | |||
| CYBN | cybin inc | 2.95 | 1,531,810 | 7,352,710 | reduced | -7.59 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DCTH | delcath systems, inc. | 12.31 | 3,300,390 | 30,627,600 | unchanged | 0.00 | ||
| EYPT | eyepoint pharmaceuticals inc | 5.37 | 1,036,740 | 13,363,500 | added | 50.25 | ||
| FENC | fennec pharmaceuticals inc | 7.19 | 2,908,200 | 17,885,400 | added | 11.28 | ||
| KURA | kura oncology inc | 0.33 | 100,000 | 813,000 | unchanged | 0.00 | ||
| LIFE | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| LPCN | lipocine inc | 0.71 | 221,616 | 1,770,710 | new | |||
| MDWD | mediwound ltd | 4.85 | 749,054 | 12,067,300 | unchanged | 0.00 | ||
| MNMD | mind medicine mindmed inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MYO | myomo inc | 1.04 | 3,847,270 | 2,599,220 | added | 0.2 | ||
| NSPR | inspiremd inc | 2.56 | 3,905,740 | 6,366,360 | unchanged | 0.00 | ||